SE385123B - METHODS OF MANUFACTURING RACEMIC OR OPTICALLY ACTIVE 13BETA-ETHYL-17ALFA-ETHYNYL-GON-4-EN-3-ON-17BETA-OL - Google Patents

METHODS OF MANUFACTURING RACEMIC OR OPTICALLY ACTIVE 13BETA-ETHYL-17ALFA-ETHYNYL-GON-4-EN-3-ON-17BETA-OL

Info

Publication number
SE385123B
SE385123B SE7307341A SE7307341A SE385123B SE 385123 B SE385123 B SE 385123B SE 7307341 A SE7307341 A SE 7307341A SE 7307341 A SE7307341 A SE 7307341A SE 385123 B SE385123 B SE 385123B
Authority
SE
Sweden
Prior art keywords
17alfa
13beta
17beta
gon
ethynyl
Prior art date
Application number
SE7307341A
Other languages
Swedish (sv)
Inventor
S Solyom
L Toldy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HUGO001205 external-priority patent/HU165356B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE385123B publication Critical patent/SE385123B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016Oximes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
SE7307341A 1972-05-26 1973-05-24 METHODS OF MANUFACTURING RACEMIC OR OPTICALLY ACTIVE 13BETA-ETHYL-17ALFA-ETHYNYL-GON-4-EN-3-ON-17BETA-OL SE385123B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO001205 HU165356B (en) 1972-05-26 1972-05-26
HUGO001225 1972-05-26

Publications (1)

Publication Number Publication Date
SE385123B true SE385123B (en) 1976-06-08

Family

ID=26318475

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7307341A SE385123B (en) 1972-05-26 1973-05-24 METHODS OF MANUFACTURING RACEMIC OR OPTICALLY ACTIVE 13BETA-ETHYL-17ALFA-ETHYNYL-GON-4-EN-3-ON-17BETA-OL

Country Status (9)

Country Link
JP (1) JPS5139217B2 (en)
AT (1) AT348151B (en)
BG (1) BG25985A3 (en)
CS (1) CS163703B2 (en)
DD (1) DD103894A5 (en)
DK (1) DK133048C (en)
NL (1) NL7306609A (en)
RO (1) RO70322A (en)
SE (1) SE385123B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5196004U (en) * 1975-01-30 1976-08-02
US4027019A (en) * 1975-07-24 1977-05-31 Ortho Pharmaceutical Corporation 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method
JPS5752103Y2 (en) * 1975-12-24 1982-11-12
JPS53110907U (en) * 1977-02-12 1978-09-05
HUP0301982A2 (en) * 2003-06-30 2005-04-28 Richter Gedeon Vegyészeti Gyár Rt. Process for the preparation of high purity d-(17alpha)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
US7576226B2 (en) 2003-06-30 2009-08-18 Richter Gedeon Vegyeszeti Gyar Rt. Process of making isomers of norelgestromin and methods using the same
WO2014175302A1 (en) * 2013-04-24 2014-10-30 あすか製薬株式会社 Amorphous levonorgestrel, solid dispersion, and manufacturing method for same

Also Published As

Publication number Publication date
DD103894A5 (en) 1974-02-12
ATA457973A (en) 1978-06-15
DK133048B (en) 1976-03-15
AT348151B (en) 1979-02-12
BG25985A3 (en) 1979-01-12
CS163703B2 (en) 1975-11-07
RO70322A (en) 1982-10-26
JPS5139217B2 (en) 1976-10-26
JPS4948651A (en) 1974-05-11
DK133048C (en) 1976-08-16
NL7306609A (en) 1973-11-28

Similar Documents

Publication Publication Date Title
SE398876B (en) METHOD OF PREPARING BASIC 1,4-DIHYDROPYRIDINCARBONIC ACID ESTERS
SE417516B (en) PROCEDURE FOR PREPARING RACEMIC OR OPTICALLY ACTIVE PIPERAZINE DERIVATIVES
NO144223C (en) PROCEDURE FOR THE MANUFACTURING OF EXTENSIVE PAPER
SE392563B (en) METHOD OF MANUFACTURING CUTTERS
BE798046A (en) PHENYL-INDANE ESTERS
SU437290A3 (en) The method of obtaining racemic or optically active piperazine derivatives
BE799254A (en) PARTIAL ESTERS
SE413245B (en) PROCEDURE FOR MANUFACTURING OPTICAL ACTIVE (+) - LAKTON- OR -TOLAKTON SOCIETY
SE385123B (en) METHODS OF MANUFACTURING RACEMIC OR OPTICALLY ACTIVE 13BETA-ETHYL-17ALFA-ETHYNYL-GON-4-EN-3-ON-17BETA-OL
SE391274B (en) METHOD OF MANUFACTURING APARTMENTS
SE397190B (en) METHOD OF PREPARING SUBSTITUTED DIBENSOCYCLOHEPTENES
NO147644C (en) PROCEDURE FOR PREPARING 6-AMINO-PENICILLANIC ACID
AT326702B (en) MICROCAPSULES
DE2213755B2 (en) MICROCAPSULES
AR196894A1 (en) OPTICAL STABILIZER
SE404192B (en) METHOD OF PREPARING 3 BETA-CYCLOALKYLOXY-16 ALFA-CYANOPREGN-5-EN-20-ONERS
DK135312B (en) Process for the production of optically active dihydrochrysanthemolactone.
DK132028B (en) Analogous process for the preparation of a racemic or optically active penicillin compound or a salt thereof.
TR17286A (en) PROCEDURE FOR THE MANUFACTURING OF UERETHANES
BE802279A (en) PENICILLINS
DK125324B (en) Analogous process for the preparation of racemic or optically active sulfamoylpyrimidines.
DK142312C (en) PROCEDURE FOR THE MANUFACTURING OF OPTICALLY ACTIVE BICYCLOAL CANDY DERIVATIVES
DK131939C (en) ANALOGICAL PROCEDURE FOR THE PRODUCTION OF RACEMIC OR OPTICALLY ACTIVE FLUOR-SUBSTITUTED ALFA-AZIDOBENZYL PENICILLIN
SE405559B (en) SET TO SOLD AND SOLD FOR EXECUTION OF THE SET
DK146717C (en) PROCEDURE FOR THE MANUFACTURING OF OPTICALLY ACTIVE INTERNAL OR NAPHTHALEND DERIVATIVES